Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia. [electronic resource]
Producer: 20041025Description: S17-21 p. digitalISSN:- 0891-1150
- Anemia -- chemically induced
- Antiviral Agents -- administration & dosage
- Clinical Trials as Topic
- Darbepoetin alfa
- Drug Therapy, Combination
- Epoetin Alfa
- Erythropoietin -- administration & dosage
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Interferons -- administration & dosage
- Interleukin-11 -- administration & dosage
- Neutropenia -- chemically induced
- Patient Compliance
- Polyethylene Glycols -- administration & dosage
- Quality of Life
- Randomized Controlled Trials as Topic
- Recombinant Proteins -- administration & dosage
- Ribavirin -- administration & dosage
- Thrombocytopenia -- chemically induced
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.